These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8387005)

  • 1. Quinolones in the pediatric patient.
    Poole MD
    Ear Nose Throat J; 1993 Feb; 72(2):162. PubMed ID: 8387005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quinolones should not be administered in monotherapy for Pseudomonas aeruginosa infection].
    Giske CG; Wretlind B
    Lakartidningen; 2006 Apr 5-11; 103(14):1121-2. PubMed ID: 16681097
    [No Abstract]   [Full Text] [Related]  

  • 3. Some newer antimicrobial agents with antipseudomonal activity.
    Pritchard RC
    Med J Aust; 1989 Jun; 150(12):708-11, 714-5. PubMed ID: 2543891
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemical structure , anti-bacterial activity and pharmacokinetics of new quinolones].
    Matsumoto F; Nishiwaki K; Morita M
    Nihon Rinsho; 1991 Oct; 49(10):2291-8. PubMed ID: 1660945
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
    Roveta S; Schito AM; Marchese A; Schito GC
    Int J Antimicrob Agents; 2005 Nov; 26(5):366-72. PubMed ID: 16216467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant pseudomonas.
    Lancet; 1969 Aug; 2(7618):473. PubMed ID: 4183911
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species.
    Rahal JJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S95-9. PubMed ID: 16894522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transmission of colistin-resistant Pseudomonas aeruginosa between patients attending a pediatric cystic fibrosis center.
    Denton M; Kerr K; Mooney L; Keer V; Rajgopal A; Brownlee K; Arundel P; Conway S
    Pediatr Pulmonol; 2002 Oct; 34(4):257-61. PubMed ID: 12205566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategy of antibiotic therapy in the course of chronic Pseudomonas aeruginosa infection].
    Bassinet L
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S118-28. PubMed ID: 12910144
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of carbenicillin in pyocyanic infections in children].
    Hongre JF
    Lille Med; 1972 Oct; 17(9):Suppl 6:1330-1. PubMed ID: 4632832
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial resistance of Pseudomonas aeruginosa in pediatric infections.
    Rodríguez-Morales AJ; Rodríguez CN; Garcia A; Pastran B; Jiménez I; Meijomil P
    Int J Infect Dis; 2007 Jan; 11(1):84-5. PubMed ID: 16581277
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance azithromycin treatment in pediatric patients with cystic fibrosis: long-term outcomes related to macrolide resistance and pulmonary function.
    Tramper-Stranders GA; Wolfs TF; Fleer A; Kimpen JL; van der Ent CK
    Pediatr Infect Dis J; 2007 Jan; 26(1):8-12. PubMed ID: 17195698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistant Pseudomonas aeruginosa bacteremia in HIV-infected patients.
    Tacconelli E; Tumbarello M; Ventura G; Lucia MB; Caponera S; Cauda R
    J Chemother; 1995 Nov; 7 Suppl 4():180-3. PubMed ID: 8904149
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanisms of resistance in Pseudomonas aeruginosa].
    Cercenado Mansilla E; García Garrote F
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():10-6. PubMed ID: 9844472
    [No Abstract]   [Full Text] [Related]  

  • 15. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre.
    Manno G; Cruciani M; Romano L; Scapolan S; Mentasti M; Lorini R; Minicucci L
    Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic quinolone antibiotics in children: a review of the use and safety.
    Grady RW
    Expert Opin Drug Saf; 2005 Jul; 4(4):623-30. PubMed ID: 16011441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of cefsulodin in the field of pediatrics].
    Iwai N; Sasaki A; Taneda Y; Mizoguchi F; Nakamura H
    Jpn J Antibiot; 1982 Nov; 35(11):2688-98. PubMed ID: 6820394
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental and clinical evaluation of cefsulodin in the field of pediatric infection].
    Toyonaga Y; Sugita M; Kurosu Y; Hori M; Hirooka J; Yokoi S; Kitani N; Takahashi T; Nishiyama H
    Jpn J Antibiot; 1982 Nov; 35(11):2657-75. PubMed ID: 6820392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.